Thomas Huben

Part of HCL Technologies Ltd., POET Holdings, Inc. is a German company that develops and markets database management and e-commerce software for enterprise customers. The company is based in Hamburg, Germany. The company was founded by Jochen Witte. POET Holdings was acquired by Versant Corp. on March 26, 2004 for $28.75 million.

Antipodean Pharmaceuticals, Inc. manufactures pharmaceutical products and provides pre clinical services. Its product MitoQ, which blocks mitochondrial oxidative damage and prevents cell death. The company was founded in 2002 and is headquartered in Menlo Park, CA.

TempestTx, Inc. is a clinical stage biotechnology company which engages in advancing small molecule therapeutics that modulate anti-tumor pathways. The company is headquartered in South San Francisco, CA.

Part of Versant Venture Management LLC, Euro Ventures 4, Inc. is a private equity fund. The company is based in Menlo Park, CA. The company was founded by Thomas F. Woiwode.

Penguin Computing, Inc. provides computer, cluster management software and technical services. It offers an end-to-end portfolio of products that range from Linux servers and workstations to integrated, turn-key HPC clusters and cluster management software. The company was founded by Sam Ockman in 1998 and is headquartered in Fremont, CA.

Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver.

Part of PricewaterhouseCoopers International Ltd., PricewaterhouseCoopers LLP is a company based in Hong Kong, Hong Kong. The Chinese company specializes in providing services to help businesses achieve their tax objectives and strategically move forward. The company's focus is on building trust in society and solving important problems, and they work closely with clients to ensure they are ready to take advantage of new opportunities for growth.

Brainloop AG provides software solutions for managing confidential information and documents. It offers document compliance management, asset management, biopharmaceutical licensing, board communication, legal department, project finance, research and development intellectual property protection, as well as investor relations and secure file protection solutions. The company was founded in 2000 and is headquartered in Munich, Germany.

Hanson Dodge, Inc. delivers branding, electronic business and integrated communications solutions. It provides research and insights, brand strategy, campaign planning and activation, content marketing, digital transformation strategy, content and commerce, web strategy and planning, user testing services. The firm serves active lifestyle and outdoors, CPG and natural products, health and wellness, travel and adventure, and work and utility industries. The company was founded by Kenneth Hanson and is headquartered in Milwaukee, WI.

7Summits LLC engages in the provision of social business consulting and agency services. It offers deep expertise in social business strategy, community experience design, platform development and integration, as well as community activation. The company was founded by Paul Stillmank and RJ Reimers in 2009 and is headquartered in Milwaukee, WI.

Inception Sciences, Inc. provides small molecule pharmaceutical incubator services. Its focus is on creating therapies with transformative potential to address diseases and disorders. The company creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded in 2011 and is headquartered in San Diego, CA.

Amberjack Global Ltd. provides recruitment services. Its solutions include strategy and design, RPO, onboarding, development, video interviewing, and apprentice solutions. The company was founded in 2000 and is headquartered in Newbury, the United Kingdom.

Anokion SA provides technology for retraining white blood cells to induce therapeutic immune tolerance. The firm?s approach to antigen-specific immune tolerance can be translated to virtually any protein in numerous clinical indications. The company was founded by Jerffery Hubbell, Melody Swartz, Stephan Kontos, Oscar Buset, Kristen M. Lorentz and David A. Lowin and is headquartered in Ecublens, Switzerland.

Kanyos Bio, Inc. engages in the provision of immune tolerance technology solutions. It develops antigen-specific for treatment of type-1 diabetes and celiac disease. The company was founded by Jeffrey Hubbell, Stephan Kontos, Oscar Buset, Kristen M. Lorentz, and David A. Lowin in 2015 and is headquartered in Cambridge, MA.

TherAchon SAS provides biotechnology services. It specializes in research and development for achondroplasia and its associated complications. The company was founded by Elvire Gouze in 2014 and is headquartered in Biot, France.

Inception IBD, Inc. provides therapeutics services. It creates new companies in partnership with pioneering academic researchers and major biopharmaceutical companies, which provide funding and a path to liquidity through pre-negotiated acquisitions. The company was founded by Eric Ogier-Denis, Yoram Bouhnik, Xavier Treton and Jacques Mizrahi in 2011 and is headquartered in San Diego, CA.

Vividion Therapeutics, Inc. operates as a biotechnology company. The company focuses on developing innovative therapeutics that treat major unmet clinical needs using the first platform for proteome wide drug and target discovery. It's proprietary chemoproteomic platform technology addresses the key limitations of conventional screening techniques and allows the discovery of previously unknown, or cryptic, functional pockets on the surface of proteins and identification of small molecules that selectively bind to those targets. The company was founded by Benjamin F. Cravatt, Phil S. Baran, Jin-Quan Yu and John K. Clarke on December 24, 2013 and is headquartered in San Diego, CA.

Versant Venture Capital VI (Canada) LP operates as a pooled investment fund. The company is headquartered in San Francisco, CA.

Jecure Therapeutics, Inc. provides therapeutic services for the treatment of non-alcoholic steatohepatitis (NASH) and liver fibrosis. The company was founded by Ariel Feldstein in 2015 and is headquartered in San Diego, CA.

Mua Agencies Ltd. provides insurance services. The private company is based in Hong Kong, Hong Kong.

CODA Biotherapeutics, Inc. engages in the development of chemo genetic neuromodulation platform for the treatment of severe neurological disorders. The company was founded by Mitchell H. Finer, Allan Basbaum, Nicholas Boulis, Joseph Glorioso III and Kenneth P. Greenberg in 2014 and is headquartered in South San Francisco, CA.